Skye Bioscience (NASDAQ: SKYE)
$3.52
(7.6%)
$0.25
Price as of August 15, 2025, 3:58 p.m. ET
Skye Bioscience Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Skye Bioscience Company Info
Skye Bioscience, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. It focuses on the treatment of a spectrum of diseases, as well as utilizing bioengineering in drug design. Its product pipeline includes SBI-100 and SBI-200. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.